Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get your Portfolio automatically emailed to you up to 4 times a day with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or
Bausch Lomb Corporation (BLCO.TO)
Bausch Lomb Corporation (BLCO.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 8,052,096
  • Shares Outstanding, K 350,701
  • Annual Sales, $ 3,768 M
  • Annual Income, $ 6,000 K
  • 60-Month Beta N/A
  • Price/Sales 1.53
  • Price/Cash Flow 56.28
  • Price/Book 0.86
Trade BLCO.TO with:
  • Price/Earnings ttm N/A
  • Earnings Per Share ttm -0.40
  • Most Recent Earnings -0.09 on 08/02/23
  • Next Earnings Date N/A
  • Annual Dividend & Yield N/A (N/A)
  • Most Recent Dividend N/A on N/A
  • Sectors:

    TSX Medical Instruments & Suppls

Price Performance

See More
Period Period Low Period High Performance
1-Month
22.65 +1.72%
on 09/21/23
25.13 -8.32%
on 08/29/23
-1.57 (-6.38%)
since 08/25/23
3-Month
22.65 +1.72%
on 09/21/23
28.96 -20.44%
on 06/30/23
-2.55 (-9.96%)
since 06/23/23
52-Week
17.80 +29.44%
on 11/03/22
28.96 -20.44%
on 06/30/23
+1.30 (+5.98%)
since 09/23/22

Most Recent Stories

More News
Stocks in play: Bausch + Lomb Corporation

Announced its ONE by ONE and Biotrue Eye Care Recycling programs have been recognized as 2023 Sustainability ...

BLCO.TO : 23.04 (+0.35%)
Stocks in play: Bausch + Lomb Corporation

Announced the U.S. commercial launch of MIEBO (perfluorohexyloctane ophthalmic solution) for the treatment ...

BLCO.TO : 23.04 (+0.35%)
Stocks in play: Bausch + Lomb Corporation

Today announced that Chairman and CEO Brent Saunders is scheduled to participate at the 2023 Wells Fargo ...

BLCO.TO : 23.04 (+0.35%)
Stocks in play: Bausch + Lomb Corporation

Announced the U.S. launch of PreserVision® AREDS 2 Formula soft gels plus coenzyme Q10 (CoQ10). Developed ...

BLCO.TO : 23.04 (+0.35%)
Stocks in play: Bausch + Lomb Corporation

Announced a reshaping of its executive leadership team, including the elevation of all business unit ...

BLCO.TO : 23.04 (+0.35%)
Bausch + Lomb Announces First-Quarter 2023 Results and Provides 2023 Guidance

Bausch + Lomb Corporation, (NYSE/TSX: BLCO) (“Bausch + Lomb” or the “Company”, “we” or “our”), a leading global eye health company dedicated to helping people see better to live better,...

BLCO : 17.18 (+0.76%)
BLCO.TO : 23.04 (+0.35%)
Bausch + Lomb Releases Annual Environmental, Social and Governance Report

Bausch + Lomb Corporation, (NYSE/TSX: BLCO) (“Bausch + Lomb” or the “Company”, “we” or “our”), a leading global eye health company dedicated to helping people see better to live better,...

BLCO : 17.18 (+0.76%)
BLCO.TO : 23.04 (+0.35%)
Bausch + Lomb Announces the Presentation of New Scientific Data on Products and Pipeline Programs at the American Society of Cataract and Refractive Surgery Annual Meeting

Bausch + Lomb Corporation (NYSE/TSX: BLCO) (“Bausch + Lomb”), a leading global eye health company dedicated to helping people see better to live better, today announced the presentation of 21 podium...

BLCO : 17.18 (+0.76%)
BLCO.TO : 23.04 (+0.35%)
Bausch + Lomb Announces 2023 Annual Meeting of Shareholder Results

Bausch + Lomb Corporation (NYSE/TSX: BLCO) (“Bausch + Lomb” or the “Company”), a leading global eye health company dedicated to helping people see better to live better, today announced the election...

BLCO : 17.18 (+0.76%)
BLCO.TO : 23.04 (+0.35%)
Bausch + Lomb Announces U.S. Launch of StableVisc™ Cohesive Ophthalmic Viscosurgical Device and TotalVisc™ Viscoelastic System

Bausch + Lomb Corporation (NYSE/TSX: BLCO) (“Bausch + Lomb”), a leading global eye health company dedicated to helping people see better to live better, today announced the U.S. launch of StableVisc™...

BLCO : 17.18 (+0.76%)
BLCO.TO : 23.04 (+0.35%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 40% Sell with a Weakening short term outlook on maintaining the current direction.

The market is approaching oversold territory. Be watchful of a trend reversal.

See More Share

Key Turning Points

3rd Resistance Point 23.11
2nd Resistance Point 23.07
1st Resistance Point 23.06
Last Price 23.04
1st Support Level 23.01
2nd Support Level 22.97
3rd Support Level 22.96

See More

52-Week High 28.96
Fibonacci 61.8% 24.70
Fibonacci 50% 23.38
Last Price 23.04
Fibonacci 38.2% 22.06
52-Week Low 17.80

See More

Business Summary

Bausch & Lomb is one of the largest vision care companies in the U.S. The firm was previously a subsidiary under parent company Bausch Health and it was spun off to become a public company in 2022. It operates in three segments: vision care, surgical, and ophthalmic pharmaceuticals. Vision care is composed...

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar